Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.

Saved in:
Bibliographic Details
Title: Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.
Authors: Leath CA 3rd; University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, United States of America. Electronic address: cleath@uabmc.edu., Deng W; NRG Statistical Center, Roswell Park Cancer Institute, Buffalo, NY, United States of America. Electronic address: dengw@nrgoncology.org., Mell LK; University of California San Diego, San Diego, CA, United States of America. Electronic address: lmell@health.ucsd.edu., Richardson DL; University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, United States of America. Electronic address: debra-richardson@ouhsc.edu., Walker JL; University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, United States of America. Electronic address: joan-walker@ouhsc.edu., Holman LL; University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, United States of America. Electronic address: laura-L-Holman@ouhsc.edu., Lea JS; University of Texas-Southwestern Medical Center, Dallas, TX, United States of America. Electronic address: Jayanthi.Lea@UTSouthwestern.edu., Amarnath SR; Cleveland Clinic Foundation, Cleveland, OH, United States of America. Electronic address: AMARNAS@ccf.org., Santos-Reyes LJ; Puerto Rico MU NCORP, Centro Comprensivo de Cancer, Puerto Rico., Arend RC; University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, Birmingham, AL, United States of America. Electronic address: rarend@uabmc.edu., Mayadev J; University of California San Diego, San Diego, CA, United States of America. Electronic address: jmayadev@health.ucsd.edu., Jegadeesh N; John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, United States of America. Electronic address: naresh.jegadeesh@cookcountyhhs.org., DiSilvestro P; Women & Infant's Hospital of Rhode Island, Legorreta Cancer Center at Brown University, Providence, RI, United States of America. Electronic address: pdisilvestro@wihri.org., Chon HS; H. Lee Moffitt Cancer Center, Tampa, FL, United States of America. Electronic address: HyeSook.Chon@moffitt.org., Ghamande SA; Augusta University, Augusta, GA, United States of America. Electronic address: sghamande@augusta.edu., Gao L; University of California San Diego, San Diego, CA, United States of America. Electronic address: legao@health.ucsd.edu., Albuquerque K; University of Texas-Southwestern Medical Center, Dallas, TX, United States of America. Electronic address: kevin.aubuquerque@utsouthwestern.edu., Chino JP; Duke Cancer Center, Department of Radiation Oncology, Durham, NC, United States of America. Electronic address: junzo.chino@duke.edu., Donnelly E; Northwestern University, Chicago, IL, United States of America. Electronic address: edonnel2@nm.org., Feddock JM; Baptist Health Hospital, Lexington, KY, United States of America., Lowenstein J; MD Anderson Cancer Center, Imaging and Radiation Oncology Core (IROC), Houston, TX, United States of America. Electronic address: jlowenst@mdanderson.org., Quick AM; The Ohio State University Medial Center, Columbus, OH, United States of America. Electronic address: Allison.Quick@osumc.edu., Kunos CM; University of Miami Miller School of Medicine, Miami, FL, United States of America. Electronic address: cak224@med.miami.edu., MacKay H; Sunnybrook Odette Cancer Centre/University of Toronto, Toronto, CA, United States of America. Electronic address: helen.mackay@sunnybrook.ca., Aghajanian C; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America. Electronic address: aghajanc@mskcc.org., Monk BJ; Florida Cancer Specialists and Research Institute, West Palm Beach, FL, United States of America. Electronic address: bmonk@gog.org.
Source: Gynecologic oncology [Gynecol Oncol] 2025 Apr; Vol. 195, pp. 122-133. Date of Electronic Publication: 2025 Mar 17.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1095-6859
DOI:10.1016/j.ygyno.2025.03.007